Inari Medical, Inc., a pioneering commercial-stage medical device company dedicated to advancing the treatment of venous diseases, has successfully raised an impressive $4.9 billion in its latest funding round. This substantial investment underscores the growing recognition of Inari Medical's innovative approach to transforming patient care within the vascular health sector. By designing cutting-edge products that address unmet needs in the treatment of various venous conditions, Inari Medical positions itself at the forefront of a vital healthcare niche. The funding will be strategically allocated to accelerate the development and launch of new technologies aimed at enhancing the quality of life for patients afflicted with these debilitating diseases. Furthermore, this capital will bolster research and development efforts, allowing the company to expand its product portfolio and reach more patients who can benefit from improved therapies. As the demand for effective solutions for venous disease continues to rise, Inari Medical is poised to innovate and lead with its commitment to excellence in medical device manufacturing. The successful fundraising round is a testament to the company’s strong market position and the confidence investors have in its future prospects to deliver life-changing solutions. With this significant influx of capital, Inari Medical is excited to embark on the next phase of its journey towards revolutionizing the treatment paradigm for venous diseases, ultimately ensuring that more patients receive the care they deserve.
Inari Medical Secures $490 Million Funding to Revolutionize Venous Disease Treatments
Get the full Inari Medical company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Chatsee
Share anonymously with strangers & make new friends with Chatsee for iOS https://chats.ee/download/
$6.5M Seed
today
Sybilla Technologies
Sybilla Technologies designs, builds, and operates robotic optical observatories for monitoring objects in space. Company specializes in the software for automated data acquisition, analysis and scheduling of networks of sensors, as well as designing and building turnkey observatories. We work in the domains of Space Situational Awareness, Space Surveillance and Tracking, Space Traffic Management, Near Earth Objects, stellar and planetary research, education, and commercial on-demand observations.
$9.3M Seed
today
esVolta, LP
Focused on sustainability and innovation, esVolta develops, owns, and operates reliable utility-scale energy storage assets across the entire lifecycle - delivering value for utilities, energy users, and investors.
$450.0M Unknown
today
Sleek
✅ Built by entrepreneurs, for entrepreneurs, Sleek’s mission is to make the lives of our fellow entrepreneurs easier. ? It is the easiest way to get started and manage a business day to day. Just one platform to digitally manage company incorporation, compliance, bookkeeping & accounting, payroll, reporting, taxes and SO much more. Sleek's human-first, tech-enabled approach helps entrepreneurs automate repetitive tasks, while our supportive experts offer the best, personalised advice to our customers. ? Present across Singapore, UK, Australia and Hong Kong, Sleek has served over 450,000 clients across 110 countries, and processed millions of bookkeeping transactions digitally. ? Sleek is registered with the company registry and tax authorities of Singapore, Hong Kong, Australia and the UK. We are also regulated by the Monetary Authority of Singapore under the Payment Services Act, and issued a Major Payment Institution (MPI) licence No. PS20200521.
$9.0M Series a
today
ARYA
GPSR ARYA Private Limited, a subsidiary of GPS Renewables Private Limited; is a high quality climate infrastructure platform with a prime focus on driving biofuels and industrial decarbonization projects, end-to-end. Inspired from the name of Aryabhatta, the renowned Indian Mathematician and Astronomer, known for his invention of ‘Zero’ and also of India’s first satellite; ARYA has been established with the one-pointed objective of responding to Climate Change by solving for Net Zero. The projects incubated, executed and commissioned under ARYA would encompass the entire array of bioenergy solutions ranging from Bio-CNG to 1G and 2G Ethanol.
$76.8M Series c
today